SKALA, Mikulas, Michal SVOBODA, Michal KOPECKY, Eva KOCOVA, Martin HYRS, Michal HOMOLAC, Viktor CHROBOK, Pavel BOSTIK, Miroslav FAJFR, Petr PRASIL, Stanislav PLISEK, Radek SLEHA and Vladimir KOBLIZEK. Heterogeneity of post‑COVID impairment: interim analysis of a prospective study from Czechia. Virology Journal. London: BioMed Central, 2021, vol. 18, No 1, p. 1-5. ISSN 1743-422X. Available from: https://dx.doi.org/10.1186/s12985-021-01546-8.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Heterogeneity of post‑COVID impairment: interim analysis of a prospective study from Czechia
Authors SKALA, Mikulas (203 Czech Republic), Michal SVOBODA (203 Czech Republic, belonging to the institution), Michal KOPECKY (203 Czech Republic), Eva KOCOVA (203 Czech Republic), Martin HYRS (203 Czech Republic), Michal HOMOLAC (203 Czech Republic), Viktor CHROBOK (203 Czech Republic), Pavel BOSTIK (203 Czech Republic), Miroslav FAJFR (203 Czech Republic), Petr PRASIL (203 Czech Republic), Stanislav PLISEK (203 Czech Republic), Radek SLEHA (203 Czech Republic) and Vladimir KOBLIZEK (203 Czech Republic, guarantor).
Edition Virology Journal, London, BioMed Central, 2021, 1743-422X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10607 Virology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.913
RIV identification code RIV/00216224:14110/21:00121484
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1186/s12985-021-01546-8
UT WoS 000639450600001
Keywords in English Post-COVID; Symptom; Lung function; 6-min Walk Test; Computer tomography
Tags 14119612, rivok
Tags International impact
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 24/8/2021 08:49.
Abstract
We stratified post-COVID patients into four newly established clinical groups based on the presence or absence of at least one subjective respiratory symptom and at least one objective sign of pulmonary involvement. Nearly half of outpatients and one third of hospitalized post-COVID patients had objective signs of pulmonary involvement without accompanying subjective respiratory symptoms three months after diagnosis.
PrintDisplayed: 15/7/2024 09:08